Cancers arise as a result of a series of genetic mutations. A better understanding of the consequences of these mutations on the underlying biology of the neoplastic cells will help to focus the development of more effective therapies. Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses challenges and alluring potential for our ability to successfully combat cancer. This symposium aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. We believe that this is an area of rapid progress in understanding cancer stem cell with immense potential to benefit human health.

This flagship event will host Dr. Michael Clarke, as a plenary speaker. Dr. Clarke’s laboratory was the first to identify breast cancer stem cells, a minority population of cancer cells that are responsible for the growth and spread of breast cancer, a process called metastasis.

Objectives

• “Cancer Stem Cells” – Introduction & Scope of research.
• Understanding the role of Cancer stem cells in Drug discovery & Development.
• Future of Cancer stem cells in Targeted Therapies

For more information click here.